Teja Celhar

1.1k total citations
18 papers, 746 citations indexed

About

Teja Celhar is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Teja Celhar has authored 18 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Rheumatology and 4 papers in Molecular Biology. Recurrent topics in Teja Celhar's work include Immune Response and Inflammation (10 papers), T-cell and B-cell Immunology (8 papers) and Systemic Lupus Erythematosus Research (7 papers). Teja Celhar is often cited by papers focused on Immune Response and Inflammation (10 papers), T-cell and B-cell Immunology (8 papers) and Systemic Lupus Erythematosus Research (7 papers). Teja Celhar collaborates with scholars based in Singapore, United States and Slovenia. Teja Celhar's co-authors include Anna‐Marie Fairhurst, Raquel Magalhães, Olga Zharkova, Petra D. Cravens, Laurie S. Davis, Sen Hee Tay, Anne B. Satterthwaite, Irena Mlinarič‐Raščan, Selma Pereira‐Lopes and John E. Connolly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.

In The Last Decade

Teja Celhar

18 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teja Celhar Singapore 14 521 250 215 111 67 18 746
Rachel Audo France 15 347 0.7× 191 0.8× 271 1.3× 102 0.9× 73 1.1× 27 662
Asuka Inoue Japan 17 331 0.6× 211 0.8× 169 0.8× 147 1.3× 55 0.8× 41 691
Jiankun Zhu United States 11 424 0.8× 107 0.4× 205 1.0× 189 1.7× 55 0.8× 16 723
Mitsuhiro Iwahashi Japan 12 449 0.9× 366 1.5× 153 0.7× 147 1.3× 47 0.7× 18 914
Dingyao Zhang United States 8 218 0.4× 226 0.9× 211 1.0× 53 0.5× 73 1.1× 15 637
J Sloan-Lancaster United States 8 733 1.4× 169 0.7× 146 0.7× 150 1.4× 58 0.9× 9 971
Wasilis Kolowos Germany 12 696 1.3× 239 1.0× 235 1.1× 63 0.6× 31 0.5× 13 863
I‐Tsu Chyuan Taiwan 17 337 0.6× 162 0.6× 242 1.1× 150 1.4× 78 1.2× 27 741
Morag R. Greer United Kingdom 6 420 0.8× 322 1.3× 365 1.7× 87 0.8× 42 0.6× 7 877
Ioannis Tassiulas United States 9 409 0.8× 168 0.7× 113 0.5× 149 1.3× 22 0.3× 17 564

Countries citing papers authored by Teja Celhar

Since Specialization
Citations

This map shows the geographic impact of Teja Celhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teja Celhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teja Celhar more than expected).

Fields of papers citing papers by Teja Celhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teja Celhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teja Celhar. The network helps show where Teja Celhar may publish in the future.

Co-authorship network of co-authors of Teja Celhar

This figure shows the co-authorship network connecting the top 25 collaborators of Teja Celhar. A scholar is included among the top collaborators of Teja Celhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teja Celhar. Teja Celhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Celhar, Teja, Ravisankar Rajarethinam, Yiping Fan, et al.. (2024). Fetal liver CD34+ contain human immune and endothelial progenitors and mediate solid tumor rejection in NOG mice. Stem Cell Research & Therapy. 15(1). 164–164. 1 indexed citations
2.
Cao, Elaine Yiqun, Lisda Suteja, Constance H. Li, et al.. (2023). Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis. Nature Communications. 14(1). 1680–1680. 65 indexed citations
3.
Celhar, Teja, Olga Zharkova, Susannah I. Thornhill, et al.. (2020). Toll-Like Receptor 9 Deficiency Breaks Tolerance to RNA-Associated Antigens and Up-Regulates Toll-Like Receptor 7 Protein in Sle1 Mice. 2 indexed citations
4.
Tay, Sen Hee, Teja Celhar, & Anna‐Marie Fairhurst. (2020). Low‐Density Neutrophils in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 72(10). 1587–1595. 64 indexed citations
5.
Celhar, Teja, Hao Lu, Larissa Rakhilina, et al.. (2019). TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner. Frontiers in Immunology. 10. 1546–1546. 17 indexed citations
6.
Qin, Ling, Huihua Ding, Ting Zhang, et al.. (2019). Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis. Arthritis Research & Therapy. 21(1). 176–176. 16 indexed citations
7.
Celhar, Teja, Olga Zharkova, Susannah I. Thornhill, et al.. (2018). Toll‐Like Receptor 9 Deficiency Breaks Tolerance to RNA‐Associated Antigens and Up‐Regulates Toll‐Like Receptor 7 Protein in Sle1 Mice. Arthritis & Rheumatology. 70(10). 1597–1609. 14 indexed citations
8.
Zharkova, Olga, Teja Celhar, Petra D. Cravens, et al.. (2017). Pathways leading to an immunological disease: systemic lupus erythematosus. Lara D. Veeken. 56(suppl_1). i55–i66. 128 indexed citations
9.
Celhar, Teja & Anna‐Marie Fairhurst. (2016). Modelling clinical systemic lupus erythematosus: similarities, differences and success stories. Lara D. Veeken. 56(suppl_1). kew400–kew400. 43 indexed citations
10.
Celhar, Teja, Richard A. Hopkins, Susannah I. Thornhill, et al.. (2015). RNA sensing by conventional dendritic cells is central to the development of lupus nephritis. Proceedings of the National Academy of Sciences. 112(45). E6195–204. 46 indexed citations
11.
Celhar, Teja, Selma Pereira‐Lopes, Susannah I. Thornhill, et al.. (2015). TLR7 and TLR9 ligands regulate antigen presentation by macrophages. International Immunology. 28(5). 223–232. 42 indexed citations
12.
Celhar, Teja & Anna‐Marie Fairhurst. (2014). Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment. Frontiers in Pharmacology. 5. 265–265. 58 indexed citations
13.
Pereira‐Lopes, Selma, Teja Celhar, Maria Paola Serra, et al.. (2013). The Exonuclease Trex1 Restrains Macrophage Proinflammatory Activation. The Journal of Immunology. 191(12). 6128–6135. 42 indexed citations
14.
Celhar, Teja, Raquel Magalhães, & Anna‐Marie Fairhurst. (2012). TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunologic Research. 53(1-3). 58–77. 165 indexed citations
15.
Celhar, Teja, et al.. (2012). EP4 receptor signalling in immature B cells involves cAMP and NF-κB dependent pathways. Journal of Pharmacy and Pharmacology. 64(8). 1090–1098. 14 indexed citations
16.
Celhar, Teja, et al.. (2011). Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells. Prostaglandins & Other Lipid Mediators. 95(1-4). 19–26. 18 indexed citations
17.
Celhar, Teja, et al.. (2008). The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancer. Cancer Genetics and Cytogenetics. 187(1). 28–33. 6 indexed citations
18.
Celhar, Teja, Tina Batista Napotnik, Aleš Obreza, et al.. (2008). Azaphenylalanine-based serine protease inhibitors induce caspase-mediated apoptosis. European Journal of Pharmacology. 602(1). 15–22. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026